Acute-On-Chronic Liver Failure - 42 Studies Found Terminated : Hepa Wash Treatment of Patients With Acute-on-Chronic Liver Failure in Intensive Care Units : Acute on Chronic Hepatic Failure : 2010-03-01 : Device: Hepa Wash Recruiting : Predicting Acute-on-Chronic Liver Failure in Cirrhosis (PREDICT) Study : Liver Cirrhosis With Acute Decompensation : 2017-02-13 : Other: Observation protocol The whole cohort will be followed for 3 months, while Group 1 will be follow Recruiting : Predictive Utility of DASIMAR as a Prognostic Biomarker in Acute-on-chronic Liver Failure (ACLF) : Liver Cirrhosis : 2010-02-18 Recruiting : Clinical Features and Natural History of Acute-on-Chronic Liver Failure in Korean Patients With Chronic Liver Disease : Chronic Liver Disease Acute Derangement of Liver Function : 2015-07-25 : Other: Acute deterioration of liver function development of new ascites within 4 weeks or re-emergence o Recruiting : Allogenic Bone Marrow Mesenchymal Stem Cell Therapy in Acute-on-chronic Liver Failure : Acute on Chronic Hepatic Failure : 2016-03-08 : Biological: Allogenic mesenchymal stem cells Recruiting : To Assess the Efficacy of High-Volume Plasma Exchange and GCSF Versus GCSF Alone in Patients of Acute on Chronic Liver Failure (ACLF). : Acute-On-Chronic Liver Failure : 2017-04-20 : Drug: Standard Medical Therapy Recruiting : To Study and Compare the Clinical Course and Development of Organ Failure in Severe Acute Hepatitis Without Ascites, Non-cirrhotic and Cirrhotic Patients With Ascites [Acute on Chronic Liver Failure] and Acute Deterioration of Previously Decompensated Cirrhosis. : Cirrhosis : 2015-06-04 Completed : Elimination of Albumin-Bound Substances by MARS and Prometheus : Liver Failure : 2006-12-01 : Device: MARS (Molecular Adsorbents Recirculating System) Completed : Prognosis Scoring System for Acute-on-Chronic Liver Failure : Liver Failure : 2013-10-09 Not yet recruiting : The Efficacy and Safety of Thymosin-α1 in Patients With HBV-related ACLF. : Liver Failure : 2017-02-23 : Drug: Thymosin-α1 1.6 mg s.c injection once per day for 7 days, then 1.6 mg s.c injection twice a w <<< Previous | Next >>>